Just when the future looked bleak for GSK’s Blenrep comeback in the U.S., the FDA has blessed the company's multiple myeloma ...

A campaign backed by Kyowa Kirin, Amgen and Sanofi is calling on prominent organizations with medical websites to bring their ...

Taiwanese drugmaker Orient Pharma and AvKARE of Tennessee have each initiated separate recalls of the high cholesterol drug ...

Roche is pausing shipments of Elevidys in some countries, following partner Sarepta Therapeutics’ move in the U.S., as safety ...

For many contract manufacturers, the end of the COVID-19 pandemic—and the production contracts that came with it—marked a ...

Ahead of the 10-year anniversary of Tagrisso’s initial FDA approval this fall, AstraZeneca has debuted the first direct-to-consumer commercial for the lung cancer med. | Ahead of the 10-year ...

Amid plans to transfer manufacturing for an investigational vaccine to a souped-up plant in Pennsylvania, GSK is parting ways ...

The PMCPA ruled that “a systemic failure in compliance oversight” at Theramex has brou | The PMCPA ruled that “a systemic ...

With the threat of tariffs looming for medicines imported to the United States, AstraZeneca has unveiled a plan to invest $50 ...

That includes the concept of microfeminism, where Pelletier admitted to being “a little bit nervous” about “swinging for the ...

As the controversy over the safety of Sarepta Therapeutics’ gene therapies comes to a head, the biotech is standing firm ...

Since starting operations in North Carolina 30 years ago, Biogen has spent approximately $10 billion to bolster its ...